Filing Details
- Accession Number:
- 0001140361-17-024611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-09 18:31:29
- Reporting Period:
- 2017-06-07
- Filing Date:
- 2017-06-09
- Accepted Time:
- 2017-06-09 18:31:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-06-07 | 1,004 | $89.61 | 47,944 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.
- All shares sold at the same price.
Billionaire Hedge Funds
